Now in its 25th year, company positions itself for continued leadership in cellular and molecular immunology and allergy testing for clinical diagnostics, life-science research, and pharmaceutical development
LENEXA, Kan., Jan. 19 /PRNewswire/ -- IBT Laboratories, a preeminent clinical-diagnostics and biomedical-research laboratory specializing in immunology and allergy assays, announced four critical additions to its executive leadership team:
“The landscape for our services has changed markedly since we started IBT Labs 25 years ago,” said John F. Halsey, Ph.D., IBT’s founder. “What began as a small, niche market has become core to the latest advances in medicine. Today, we are recognized worldwide as leaders in immunology and allergy testing, known for both the quality of our results, and our expertise in assay development. Over the past several years we have enjoyed double-digit growth in all segments of our business. Breakthrough biomarker discoveries, new protein-based therapeutics that work by triggering the body’s immune system, and the steady progress toward ‘personalized medicine’ will continue to drive the demand for our services to physicians and pharmaceutical-development companies in the years to come.”
Dr. Halsey continued, “We’re now structuring the company for the future. In May, Maureen Loftus joined us as president. She, along with our talented and expanded leadership team, is responsible for execution of IBT’s growth strategy. Effective this month, I have retired from an active company-management role to focus my time and energy on my position as IBT’s clinical laboratory director and senior scientific advisor. I also remain a member of IBT’s board of directors. However, our mission has not changed: to develop novel assays and serve customers with the most accurate, reliable, and comprehensive suite of immunological tests available by applying the latest scientific discoveries to cutting-edge clinical methodologies. For anyone interested in the future of diagnostic testing - IBT is clearly a company to watch.”
About IBT Laboratories (www.ibtlabs.com)
A clinical diagnostic and research laboratory specializing in immunology and allergy testing, IBT tests patient samples for physicians, hospitals, and commercial reference labs nationwide. IBT also provides biomarker and immunogenicity testing services to pharmaceutical and biotechnology companies and life-science researchers. Founded in 1983, IBT is privately held and centrally located in Lenexa, Kansas, a suburb of Kansas City. For complete executive bios, please visit, www.ibtlabs.com/about_us/leadership.asp
CONTACT: Caroline Grossman for IBT Laboratories, +1-781-771-5579,
Caroline.grossman@gmail.com
Web site: http://www.ibtlabs.com/
